pyruvic acid and minocycline

pyruvic acid has been researched along with minocycline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, HB; McLarnon, JG; Ryu, JK1
Norenberg, MD; Rama Rao, KV; Reddy, PV1
Goard, CA; Gronda, M; Hurren, R; Jhas, B; Jitkova, Y; Schimmer, AD; Wang, X1

Other Studies

3 other study(ies) available for pyruvic acid and minocycline

ArticleYear
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
    Neuroscience, 2006, Sep-15, Volume: 141, Issue:4

    Topics: Analysis of Variance; Animals; Blotting, Western; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Drug Synergism; Huntington Disease; Immunohistochemistry; Inflammation; Male; Minocycline; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2006
Inhibitors of the mitochondrial permeability transition reduce ammonia-induced cell swelling in cultured astrocytes.
    Journal of neuroscience research, 2009, Volume: 87, Issue:12

    Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Brain; Brain Edema; Cell Size; Cells, Cultured; Cyclosporine; Hepatic Encephalopathy; Hyperammonemia; Magnesium; Minocycline; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Pyruvic Acid; Rats; Trifluoperazine; Water-Electrolyte Balance

2009
A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Drug Stability; Humans; Immunoblotting; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Minocycline; Pyruvic Acid; Tigecycline

2014